← Leaderboards
Warren E Rose
University Of Wisconsin-Madison
$2,851,744
Attributed
$3,615,469
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $764.4K · FY2017–25$1M$750K$500K$250K$0
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$3,615,469 · 2
By mechanism
R01$3,615,469 · 2
Top collaborators
- David J Beebe2 shared
Most similar at University Of Wisconsin-Madison
Same institution · by research overlap
- David J Beebe$20,083,426
Others in their field
Other Emerging Leaders on “Screening”
- Leonard Freedman · Leidos Biomedical Research, Inc.$310,487,925
- Lynn Briscoe · Leidos Biomedical Research, Inc.$121,890,535
- Yunda Huang · Fred Hutchinson Cancer Center$58,111,165
- Leonard Freedmand · Leidos Biomedical Research, Inc.$57,401,321
- John Damon Chodera · Sloan-Kettering Inst Can Research$53,758,943
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$33,980,897
Research focus
ScreeningAntimicrobialInfectionLaboratoriesBacterial InfectionsResistanceSurfaceHuman PathogenClinical EfficacyCefazolinCell WallCell MembraneBacteremiaCharacteristicsClinical PracticeAffinityBeta-LactamsAntibioticsBlood PlateletsBindingBaseBinding ProteinsBiological ModelsBactericide
Grant awards (7)
Exclusive liquid repellency enables next-generation phenotypic antimicrobial susceptibility testing$763,028
R01 · FY2025 · AI · contact PI
Exclusive liquid repellency enables next-generation phenotypic antimicrobial susceptibility testing$764,423
R01 · FY2024 · AI · contact PI
Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment$332,642
R01 · FY2021 · AI · contact PI
Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment$355,592
R01 · FY2020 · AI · contact PI
Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment$486,349
R01 · FY2019 · AI · contact PI
Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment$469,355
R01 · FY2018 · AI · contact PI
Mechanisms and use of penicillin-binding protein inhibition to optimize cationic peptide anti-MRSA treatment$444,080
R01 · FY2017 · AI · contact PI